for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Zynerba Pharmaceuticals Announces Top Line Results From Pivotal Connect-FX Trial Of Zygel

June 30 (Reuters) - Zynerba Pharmaceuticals Inc:

* ZYNERBA PHARMACEUTICALS ANNOUNCES TOP LINE RESULTS FROM PIVOTAL CONNECT-FX TRIAL OF ZYGEL™ (CBD GEL) IN FRAGILE X SYNDROME

* ZYNERBA PHARMACEUTICALS INC - STUDY DID NOT ACHIEVE STATISTICAL SIGNIFICANCE IN PRIMARY OR KEY SECONDARY ENDPOINTS IN FULL ANALYSIS SET Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up